These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6348577)

  • 41. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage.
    Vollmer DG; Hongo K; Ogawa H; Tsukahara T; Kassell NF
    Neurosurgery; 1991 Jan; 28(1):27-32. PubMed ID: 1994279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Conservative principles in the therapy of subarachnoid hemorrhage].
    von Planta M; Ritz R
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1333-7. PubMed ID: 3527644
    [No Abstract]   [Full Text] [Related]  

  • 43. [Correlation of vasospasm with operative results in ruptured aneurysms].
    Nitta M; Nagai H; Hara M; Tanaka H; Shintani A; Takagi T; Hori H; Ito H; Maeda S
    No Shinkei Geka; 1982 Aug; 10(8):823-9. PubMed ID: 7133303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Effects of Red Blood Cell Transfusion on Functional Outcome after Aneurysmal Subarachnoid Hemorrhage.
    Kumar MA; Levine J; Faerber J; Elliott JP; Winn HR; Doerfler S; Le Roux P
    World Neurosurg; 2017 Dec; 108():807-816. PubMed ID: 29038077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kanamaru K; Grace M; Baughman R
    Neurosurgery; 1990 Feb; 26(2):201-6. PubMed ID: 2106630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypovolemia in patients with subarachnoid hemorrhage: therapeutic implications.
    Maroon JC; Nelson PB
    Neurosurgery; 1979 Mar; 4(3):223-6. PubMed ID: 460553
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical-radiological correlations of cerebral vasospasm and cerebral infarction in patients after subarachnoid hemorrhage].
    Danilewicz B; Stachura K; Kamieniecka B
    Neurol Neurochir Pol; 1990; 24(5-6):309-14. PubMed ID: 2131428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum complements as indicator for predicting vasospasm and its severity after aneurysmal subarachnoid hemorrhage.
    Kawano T; Yonekawa Y
    Nihon Geka Hokan; 1990 May; 59(3):189-97. PubMed ID: 2130781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.
    Murayama Y; Malisch T; Guglielmi G; Mawad ME; Viñuela F; Duckwiler GR; Gobin YP; Klucznick RP; Martin NA; Frazee J
    J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulatory volume expansion for aneurysmal subarachnoid hemorrhage.
    Feigin VL; Rinkel GJ; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2000; (2):CD000483. PubMed ID: 10796370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced incidence of cerebral ischemia following rupture of intracranial aneurysms.
    Zervas NT; Candia M; Candia G; Kido D; Pessin MS; Rosoff CB; Bacon V
    Surg Neurol; 1979 May; 11(5):339-44. PubMed ID: 375449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
    Ohkuma H; Parney I; Megyesi J; Ghahary A; Findlay JM
    J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report.
    Mizoi K; Yoshimoto T; Fujiwara S; Sugawara T; Takahashi A; Koshu K
    Neurosurgery; 1991 Jun; 28(6):807-12; discussion 812-3. PubMed ID: 1906142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Optimal hypervolemic therapy for symptomatic vasospasm].
    Shimoda M; Oda S; Hidaka M; Shibata M; Yamamoto I; Sato O; Tsugane R
    No Shinkei Geka; 1991 Jan; 19(1):35-40. PubMed ID: 2000155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computed tomographic grading with Hounsfield number related to delayed vasospasm in cases of ruptured cerebral aneurysm.
    Fujita S
    Neurosurgery; 1985 Oct; 17(4):609-12. PubMed ID: 4058698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The experiences of a large amount of steroid therapy for symptomatic vasospasm after subarachnoid hemorrhage: clinical analysis of 21 cases].
    Yasukawa K; Kamijou Y; Momose G; Kobayashi S; Kuroyanagi T; Morota N; Unoki T
    No Shinkei Geka; 1994 Jan; 22(1):17-22. PubMed ID: 8295697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Subarachnoid hemorrhage of unknown etiology: management, prognosis, and predictive factors].
    Bucciero A; Vizioli L; Tedeschi G
    Minerva Med; 1993 Jun; 84(6):323-7. PubMed ID: 8336840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
    Seifert V; Eisert WG; Stolke D; Goetz C
    Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [High dose nicardipine therapy for delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage].
    Kohno H; Kawano T; Tanaka N; Honma T; Okada T; Satoh K
    No Shinkei Geka; 1993 Nov; 21(11):999-1003. PubMed ID: 8255388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms.
    Auer LM
    Neurosurgery; 1984 Jul; 15(1):57-66. PubMed ID: 6472595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.